• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TβRIII介导的TGF-β信号传导抑制以及乳腺癌迁移和侵袭需要TβRIII的胞外域脱落。

Ectodomain shedding of TβRIII is required for TβRIII-mediated suppression of TGF-β signaling and breast cancer migration and invasion.

作者信息

Elderbroom Jennifer L, Huang Jennifer J, Gatza Catherine E, Chen Jian, How Tam, Starr Mark, Nixon Andrew B, Blobe Gerard C

机构信息

Department of Pharmacology and Cancer Biology, Duke University, Durham, NC 27708.

Department of Medicine, Duke University, Durham, NC 27708.

出版信息

Mol Biol Cell. 2014 Aug 15;25(16):2320-32. doi: 10.1091/mbc.E13-09-0524. Epub 2014 Jun 25.

DOI:10.1091/mbc.E13-09-0524
PMID:24966170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4142606/
Abstract

The type III transforming growth factor β (TGF-β) receptor (TβRIII), also known as betaglycan, is the most abundantly expressed TGF-β receptor. TβRIII suppresses breast cancer progression by inhibiting migration, invasion, metastasis, and angiogenesis. TβRIII binds TGF-β ligands, with membrane-bound TβRIII presenting ligand to enhance TGF-β signaling. However, TβRIII can also undergo ectodomain shedding, releasing soluble TβRIII, which binds and sequesters ligand to inhibit downstream signaling. To investigate the relative contributions of soluble and membrane-bound TβRIII on TGF-β signaling and breast cancer biology, we defined TβRIII mutants with impaired (ΔShed-TβRIII) or enhanced ectodomain shedding (SS-TβRIII). Inhibiting ectodomain shedding of TβRIII increased TGF-β responsiveness and abrogated TβRIII's ability to inhibit breast cancer cell migration and invasion. Conversely, expressing SS-TβRIII, which increased soluble TβRIII production, decreased TGF-β signaling and increased TβRIII-mediated inhibition of breast cancer cell migration and invasion. Of importance, SS-TβRIII-mediated increases in soluble TβRIII production also reduced breast cancer metastasis in vivo. Taken together, these studies suggest that the ratio of soluble TβRIII to membrane-bound TβRIII is an important determinant for regulation of TβRIII- and TGF-β-mediated signaling and biology.

摘要

III型转化生长因子β(TGF-β)受体(TβRIII),也称为β聚糖,是表达最为丰富的TGF-β受体。TβRIII通过抑制迁移、侵袭、转移和血管生成来抑制乳腺癌进展。TβRIII结合TGF-β配体,膜结合型TβRIII呈递配体以增强TGF-β信号传导。然而,TβRIII也可发生胞外域脱落,释放可溶性TβRIII,其结合并隔离配体以抑制下游信号传导。为了研究可溶性和膜结合型TβRIII对TGF-β信号传导和乳腺癌生物学的相对贡献,我们定义了胞外域脱落受损(ΔShed-TβRIII)或增强(SS-TβRIII)的TβRIII突变体。抑制TβRIII的胞外域脱落增加了TGF-β反应性,并消除了TβRIII抑制乳腺癌细胞迁移和侵袭的能力。相反地,表达增加可溶性TβRIII产生的SS-TβRIII降低了TGF-β信号传导,并增强了TβRIII介导的对乳腺癌细胞迁移和侵袭的抑制作用。重要的是,SS-TβRIII介导的可溶性TβRIII产生增加也减少了体内乳腺癌转移。综上所述,这些研究表明可溶性TβRIII与膜结合型TβRIII的比例是调节TβRIII和TGF-β介导的信号传导及生物学特性的重要决定因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297e/4142606/d5b4bdadb737/2320fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297e/4142606/bc02be50a206/2320fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297e/4142606/69be9f1488bf/2320fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297e/4142606/1cc4dc7cf62a/2320fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297e/4142606/6479451c20e1/2320fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297e/4142606/afcc4113c617/2320fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297e/4142606/d5b4bdadb737/2320fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297e/4142606/bc02be50a206/2320fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297e/4142606/69be9f1488bf/2320fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297e/4142606/1cc4dc7cf62a/2320fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297e/4142606/6479451c20e1/2320fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297e/4142606/afcc4113c617/2320fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297e/4142606/d5b4bdadb737/2320fig6.jpg

相似文献

1
Ectodomain shedding of TβRIII is required for TβRIII-mediated suppression of TGF-β signaling and breast cancer migration and invasion.TβRIII介导的TGF-β信号传导抑制以及乳腺癌迁移和侵袭需要TβRIII的胞外域脱落。
Mol Biol Cell. 2014 Aug 15;25(16):2320-32. doi: 10.1091/mbc.E13-09-0524. Epub 2014 Jun 25.
2
The balance of cell surface and soluble type III TGF-β receptor regulates BMP signaling in normal and cancerous mammary epithelial cells.细胞表面与可溶性III型转化生长因子-β受体的平衡调节正常和癌性乳腺上皮细胞中的骨形态发生蛋白信号传导。
Neoplasia. 2014 Jun;16(6):489-500. doi: 10.1016/j.neo.2014.05.008.
3
The type III TGF-beta receptor suppresses breast cancer progression.III型转化生长因子β受体抑制乳腺癌进展。
J Clin Invest. 2007 Jan;117(1):206-17. doi: 10.1172/JCI29293. Epub 2006 Dec 7.
4
Increased type III TGF-β receptor shedding decreases tumorigenesis through induction of epithelial-to-mesenchymal transition.III 型 TGF-β 受体脱落增加通过诱导上皮-间充质转化抑制肿瘤发生。
Oncogene. 2019 May;38(18):3402-3414. doi: 10.1038/s41388-018-0672-7. Epub 2019 Jan 14.
5
The type III TGF-beta receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-beta signaling.III 型 TGF-β 受体通过 GIPC 介导的 TGF-β 信号抑制抑制乳腺癌的进展。
Carcinogenesis. 2010 Feb;31(2):175-83. doi: 10.1093/carcin/bgp271. Epub 2009 Dec 2.
6
Type III TGF-β receptor enhances colon cancer cell migration and anchorage-independent growth.III 型转化生长因子-β受体增强结肠癌细胞的迁移和非锚定依赖性生长。
Neoplasia. 2011 Aug;13(8):758-70. doi: 10.1593/neo.11528.
7
Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.III型转化生长因子β受体表达缺失会增加胰腺癌进展过程中与上皮-间质转化相关的迁移和侵袭能力。
Carcinogenesis. 2008 Feb;29(2):252-62. doi: 10.1093/carcin/bgm249. Epub 2007 Nov 13.
8
A tumor-promoting role for soluble TβRIII in glioblastoma.可溶性 TβRIII 在胶质母细胞瘤中的促瘤作用。
Mol Cell Biochem. 2021 Aug;476(8):2963-2973. doi: 10.1007/s11010-021-04128-y. Epub 2021 Mar 26.
9
Decreased expression of the type III TGF-β receptor enhances metastasis and invasion in hepatocellullar carcinoma progression.III型转化生长因子-β受体表达降低会增强肝癌进展中的转移和侵袭能力。
Oncol Rep. 2016 Apr;35(4):2373-81. doi: 10.3892/or.2016.4615. Epub 2016 Feb 8.
10
The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2.III型转化生长因子-β受体通过与β-抑制蛋白2相互作用负向调节核因子κB信号通路。
Carcinogenesis. 2009 Aug;30(8):1281-7. doi: 10.1093/carcin/bgp071. Epub 2009 Mar 26.

引用本文的文献

1
Apoptotic Caspases-3 and -7 Cleave Extracellular Domains of Membrane-Bound Proteins from MDA-MB-231 Breast Cancer Cells.凋亡性半胱天冬酶-3和-7切割MDA-MB-231乳腺癌细胞膜结合蛋白的细胞外结构域。
Int J Mol Sci. 2025 Apr 8;26(8):3466. doi: 10.3390/ijms26083466.
2
Structures of TGF-β with betaglycan and signaling receptors reveal mechanisms of complex assembly and signaling.转化生长因子-β(TGF-β)与β-聚糖及信号受体的结构揭示了复合物组装和信号传导机制。
Nat Commun. 2025 Feb 26;16(1):1778. doi: 10.1038/s41467-025-56796-9.
3
Betaglycan sustains HGF/Met signaling in lung cancer and endothelial cells promoting cell migration and tumor growth.

本文引用的文献

1
The balance of cell surface and soluble type III TGF-β receptor regulates BMP signaling in normal and cancerous mammary epithelial cells.细胞表面与可溶性III型转化生长因子-β受体的平衡调节正常和癌性乳腺上皮细胞中的骨形态发生蛋白信号传导。
Neoplasia. 2014 Jun;16(6):489-500. doi: 10.1016/j.neo.2014.05.008.
2
Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment.III 型 TGF-β 受体下调可产生免疫耐受的肿瘤微环境。
J Clin Invest. 2013 Sep;123(9):3925-40. doi: 10.1172/JCI65745. Epub 2013 Aug 8.
3
PROSPER: an integrated feature-based tool for predicting protease substrate cleavage sites.
β聚糖维持肺癌和内皮细胞中的HGF/Met信号传导,促进细胞迁移和肿瘤生长。
Heliyon. 2024 Apr 30;10(9):e30520. doi: 10.1016/j.heliyon.2024.e30520. eCollection 2024 May 15.
4
Glycosaminoglycan modifications of betaglycan regulate ectodomain shedding to fine-tune TGF-β signaling responses in ovarian cancer.β 聚糖蛋白聚糖的糖胺聚糖修饰调节其外显肽脱落,从而精细调控卵巢癌细胞中 TGF-β 信号转导反应。
Cell Commun Signal. 2024 Feb 15;22(1):128. doi: 10.1186/s12964-024-01496-y.
5
Screening of novel serum biomarkers for gastric cancer in coastal populations using a protein microarray.应用蛋白质微阵列筛选沿海人群胃癌新型血清标志物。
Cancer Sci. 2023 Aug;114(8):3396-3410. doi: 10.1111/cas.15876. Epub 2023 Jun 8.
6
Computational modeling of TGF-β2:TβRI:TβRII receptor complex assembly as mediated by the TGF-β coreceptor betaglycan.TGF-β2:TβRI:TβRII 受体复合物组装的计算建模,由 TGF-β 辅助受体 betaglycan 介导。
Biophys J. 2023 Apr 4;122(7):1342-1354. doi: 10.1016/j.bpj.2023.02.030. Epub 2023 Mar 3.
7
Colocalization with MMP-7 in the Distal Colon is Crucial for Syndecan-2 Shedding in Dextran Sulfate Sodium-Induced Colitis Mice.在远端结肠中与基质金属蛋白酶-7共定位对硫酸葡聚糖钠诱导的结肠炎小鼠中Syndecan-2的脱落至关重要。
J Inflamm Res. 2021 Sep 29;14:4987-5000. doi: 10.2147/JIR.S329234. eCollection 2021.
8
Canonical TGFβ Signaling and Its Contribution to Endometrial Cancer Development and Progression-Underestimated Target of Anticancer Strategies.经典TGFβ信号通路及其在子宫内膜癌发生发展中的作用——抗癌策略中被低估的靶点
J Clin Med. 2021 Aug 30;10(17):3900. doi: 10.3390/jcm10173900.
9
Type III TGF-β Receptor Down-Regulation Promoted Tumor Progression via Complement Component C5a Induction in Hepatocellular Carcinoma.III型转化生长因子-β受体下调通过诱导补体成分C5a促进肝癌进展。
Cancers (Basel). 2021 Mar 25;13(7):1503. doi: 10.3390/cancers13071503.
10
TGF-β superfamily co-receptors in cancer.TGF-β 超家族共受体在癌症中的作用。
Dev Dyn. 2022 Jan;251(1):137-163. doi: 10.1002/dvdy.338. Epub 2021 Apr 9.
PROSPER:一种基于综合特征的蛋白酶底物切割位点预测工具。
PLoS One. 2012;7(11):e50300. doi: 10.1371/journal.pone.0050300. Epub 2012 Nov 29.
4
Complexities of TGF-β targeted cancer therapy.TGF-β 靶向癌症治疗的复杂性。
Int J Biol Sci. 2012;8(7):964-78. doi: 10.7150/ijbs.4564. Epub 2012 Jul 12.
5
Cancer statistics, 2012.癌症统计数据,2012 年。
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
6
TRAF6 ubiquitinates TGFβ type I receptor to promote its cleavage and nuclear translocation in cancer.TRAF6 通过泛素化 TGFβ 型 I 受体促进其在癌症中的裂解和核转位。
Nat Commun. 2011;2:330. doi: 10.1038/ncomms1332.
7
The type III transforming growth factor-β receptor inhibits proliferation, migration, and adhesion in human myeloma cells.III 型转化生长因子-β 受体抑制人骨髓瘤细胞的增殖、迁移和黏附。
Mol Biol Cell. 2011 May;22(9):1463-72. doi: 10.1091/mbc.E10-11-0877. Epub 2011 Mar 16.
8
The type III TGF-β receptor betaglycan transmembrane-cytoplasmic domain fragment is stable after ectodomain cleavage and is a substrate of the intramembrane protease γ-secretase.III型转化生长因子β受体β聚糖跨膜-胞质结构域片段在胞外结构域裂解后是稳定的,并且是膜内蛋白酶γ-分泌酶的底物。
Biochim Biophys Acta. 2011 Feb;1813(2):332-9. doi: 10.1016/j.bbamcr.2010.12.005. Epub 2010 Dec 15.
9
The cytoplasmic domains of TNFalpha-converting enzyme (TACE/ADAM17) and L-selectin are regulated differently by p38 MAPK and PKC to promote ectodomain shedding.肿瘤坏死因子α转化酶(TACE/ADAM17)和 L-选择素的细胞质结构域受 p38 MAPK 和 PKC 的不同调节,以促进细胞外结构域的脱落。
Biochem J. 2010 May 13;428(2):293-304. doi: 10.1042/BJ20091611.
10
The emerging role of TGF-beta superfamily coreceptors in cancer.转化生长因子-β超家族共受体在癌症中的新作用。
Biochim Biophys Acta. 2009 Oct;1792(10):954-73. doi: 10.1016/j.bbadis.2009.07.003. Epub 2009 Jul 14.